| Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543322 |
NSE Symbol : ALIVUS |
P/E(TTM) : 25.85 |
|
ISIN Demat : INE03Q201024 |
Div & Yield% : 0.38 |
EPS(TTM) : 50.64 |
|
Book Value(₹) : 271.41 |
Market Cap(₹Cr) : 16,072.62 |
Face Value(₹) : 2.00 |
| Particulars | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Long Term Debt-Equity Ratio | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
| Current Ratio | 3.37 | 3.70 | 3.65 | 3.78 | 1.90 |
| Fixed Assets | 1.97 | 2.14 | 2.34 | 2.62 | 3.12 |
| Inventory | 3.74 | 3.56 | 3.59 | 3.86 | 4.12 |
| Debtors | 2.50 | 2.75 | 2.90 | 2.92 | 3.28 |
| Interest Cover Ratio | 140.91 | 272.42 | 408.28 | 1143.93 | 21.20 |
| PBIDTM (%) | 32.61 | 30.05 | 30.06 | 31.06 | 29.71 |
| PBITM (%) | 29.65 | 27.51 | 27.72 | 29.11 | 27.92 |
| PBDTM (%) | 32.40 | 29.94 | 29.99 | 31.03 | 28.39 |
| CPM (%) | 25.07 | 22.89 | 22.97 | 23.55 | 21.51 |
| APATM (%) | 22.12 | 20.35 | 20.62 | 21.61 | 19.72 |
| ROCE (%) | 23.95 | 24.97 | 27.94 | 29.80 | 42.20 |
| RONW (%) | 18.36 | 18.86 | 21.07 | 22.28 | 29.83 |
